Stay updated with breaking news from Mark Berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genprex Inc (NASDAQ: GNPX) is a clinical-stage gene therapy organization that concentrates on the development of life-changing gene therapies to treat people with diabetes and cancer. The company announced that it had received FTD (Fast Track Designation) from the Food and Drug Administration for its REQORSA Immunogene therapy and went up by 130%. This lead drug […]
"We are thrilled to receive a second Fast Track designation from the FDA for REQORSA in patients with late-stage NSCLC, this time in...
/PRNewswire/ -- Minneapolis-based wealth management firm, Berger Financial Group, Inc. is excited to announce its acquisition of Dane Holdings, Inc., a...
The new mandate is likely to have a big impact on Louisiana, which has had one of the lowest COVID-19 vaccination rates among nursing home workers
The new mandate is likely to have a big impact on Louisiana, which has had one of the lowest COVID-19 vaccination rates among nursing home workers